| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5826079 | Current Opinion in Pharmacology | 2014 | 5 Pages |
Abstract
In this context the interest in the modulation of ghrelin pathway is still very high although, so far, only ghrelin agonism has confirmed its therapeutic potential in cachectic patients. Unfortunately, ghrelin modulation does not offer a therapeutic option for Anorexia Nervosa, where novel promising pharmacological treatments are still to be uncovered.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Sergio Melotto,